Literature DB >> 6127152

Flunitrazepam binding sites in rat diaphragm. Receptors for direct neuromuscular effects of benzodiazepines?

M Wilkinson, D Grovestine, J T Hamilton.   

Abstract

The evidence for direct muscle relaxant effects of benzodiazepines is controversial. We now show that a crude membrane preparation of rat diaphragm possesses binding sites for [3H]flunitrazepam (FNZ). Scatchard analysis gave a binding site density of 1689 +/- 143 fmol/mg protein (Kd = 25.6 +/- 2.6 nM). These sites are of the "peripheral" type since clonazepam fails to displace [3H]FNZ as effectively as R05-4864 (IC50 values: 7.5 x 10(-6) M and 8 x 10(-9) M, respectively). Diazepam is almost as effective as R05-4864 and potently displaces [3H]FNZ binding (IC50 = 3 x 10(-8) M). We propose that the previously described effects of diazepam on rat diaphragm are mediated through high-affinity binding sites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127152     DOI: 10.1139/y82-142

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  4 in total

1.  Autoradiographic localization of "peripheral-type" benzodiazepine binding sites in the rat brain, heart and kidney.

Authors:  D R Gehlert; H I Yamamura; J K Wamsley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

2.  Enhancement by benzodiazepines of the inhibitory effect of adenosine on skeletal neuromuscular transmission.

Authors:  L C Chiou; J Y Ling; C C Chang
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

3.  Pharmacological relevance of peripheral type benzodiazepine receptors on motor nerve and skeletal muscle.

Authors:  L C Chiou; C C Chang
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

4.  Peripheral benzodiazepine binding sites on striated muscles of the rat: properties and effect of denervation.

Authors:  W E Müller; A Ickstadt; H C Hopf
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.